PARP Inhibitor Therapy for Ovarian Cancer: Practical Prescribing and Medication Management

Earn CME credit: <a target='_blank' href='https://www.naccme.com/program/2018-i7956-1'>https://www.naccme.com/prog...</a><br /><br />PARP inhibitors are the most commonly used targeted therapy for patients with recurrent ovarian cancer, and the indications for the use ... Author: imedex Added: 04/03/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts